SEC Filing Summary: Prana Biotechnology Limited
Business Context and Reporting Period
This Form 6-K was filed by Prana Biotechnology Limited, a foreign private issuer based in South Melbourne, Australia, for the month of October 2007. The report was signed by Geoffrey Kempler, Executive Chairman, on October 22, 2007. The filing specifically addresses a notice of change of interest by a substantial holder, Jagen Nominees Pty Ltd.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a regulatory notice regarding shareholding changes and does not contain financial statements or performance metrics.
Material Changes
- Substantial Holder Change: The filing reports a change of interest by Jagen Nominees Pty Ltd. Specific details regarding the magnitude or direction of this change are not detailed in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for management guidance, future outlook, risk factors, contingencies, or unusual items. The document is limited to the notification of the substantial holder's change in interest.
Investor Verification Checklist
- Verify the specific percentage change in holdings for Jagen Nominees Pty Ltd in the full regulatory notice.
- Confirm the total share capital and current ownership structure of Prana Biotechnology Limited.
- Review subsequent filings for any financial updates or operational developments not included in this notice.